Novel Liver Support System for Improving Survival Rate Under Development

Published: 2005-01-19 06:57:00

Updated: 2005-01-19 06:57:00

Lifecord Co., a domestic company specialized in the cord blood storage, is currently undertaking a joint development project of the hepatocyte-based liver support system for patients with acute hepatic failures, with participating collaborations from the local universities and hospitals.

Funde...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK